Literature DB >> 28860268

Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress?

Danielle Cazabon1, Anita Suresh1, Collins Oghor2, Zhi Zhen Qin3, Sandra V Kik4, Claudia M Denkinger5, Madhukar Pai6,7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28860268     DOI： 10.1183/13993003.00918-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Xpert(®) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.

Authors:  N B Mbonze; M Tabala; L K Wenzi; B Bakoko; M Brouwer; J Creswell; A Van Rie; F Behets; M Yotebieng
Journal:  Int J Tuberc Lung Dis       Date:  2016-02       Impact factor: 2.373

2.  Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.

Authors:  K Charambira; S Ade; A D Harries; R T Ncube; C Zishiri; C Sandy; H Mutunzi; K Takarinda; P Owiti; P Mafaune; P Chonzi
Journal:  Public Health Action       Date:  2016-06-21

3.  Replacing smear microscopy for the diagnosis of tuberculosis: what is the market potential?

Authors:  Sandra V Kik; Claudia M Denkinger; Pamela Chedore; Madhukar Pai
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

4.  How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?

Authors:  Zhi Zhen Qin; Madhukar Pai; Wayne Van Gemert; Suvanand Sahu; Marzieh Ghiasi; Jacob Creswell
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

5.  From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts.

Authors:  Srinath Satyanarayana; Sreenivas Achutan Nair; Sarabjit Singh Chadha; Roopa Shivashankar; Geetanjali Sharma; Subhash Yadav; Subrat Mohanty; Vishnuvardhan Kamineni; Nevin Charles Wilson; Anthony David Harries; Puneet Kumar Dewan
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

6.  Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries.

Authors:  Jacob Creswell; Andrew J Codlin; Emmanuel Andre; Mark A Micek; Ahmed Bedru; E Jane Carter; Rajendra-Prasad Yadav; Andrei Mosneaga; Bishwa Rai; Sayera Banu; Miranda Brouwer; Lucie Blok; Suvanand Sahu; Lucica Ditiu
Journal:  BMC Infect Dis       Date:  2014-01-02       Impact factor: 3.090

7.  Tuberculosis innovations mean little if they cannot save lives.

Authors:  Madhukar Pai; Jennifer Furin
Journal:  Elife       Date:  2017-05-02       Impact factor: 8.140
  7 in total
  18 in total

Review 1.  High-quality health systems in the Sustainable Development Goals era: time for a revolution.

Authors:  Margaret E Kruk; Anna D Gage; Catherine Arsenault; Keely Jordan; Hannah H Leslie; Sanam Roder-DeWan; Olusoji Adeyi; Pierre Barker; Bernadette Daelmans; Svetlana V Doubova; Mike English; Ezequiel García-Elorrio; Frederico Guanais; Oye Gureje; Lisa R Hirschhorn; Lixin Jiang; Edward Kelley; Ephrem Tekle Lemango; Jerker Liljestrand; Address Malata; Tanya Marchant; Malebona Precious Matsoso; John G Meara; Manoj Mohanan; Youssoupha Ndiaye; Ole F Norheim; K Srinath Reddy; Alexander K Rowe; Joshua A Salomon; Gagan Thapa; Nana A Y Twum-Danso; Muhammad Pate
Journal:  Lancet Glob Health       Date:  2018-09-05       Impact factor: 26.763

2.  Detecting tuberculosis: rapid tools but slow progress.

Authors:  K England; T Masini; E Fajardo
Journal:  Public Health Action       Date:  2019-09-21

3.  Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.

Authors:  Samuel G Schumacher; William A Wells; Mark P Nicol; Karen R Steingart; Grant Theron; Susan E Dorman; Madhukar Pai; Gavin Churchyard; Lesley Scott; Wendy Stevens; Pamela Nabeta; David Alland; Karin Weyer; Claudia M Denkinger; Christopher Gilpin
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

Review 4.  Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.

Authors:  Nora Engel; Eleanor A Ochodo; Perpetua Wanjiku Karanja; Bey-Marrié Schmidt; Ricky Janssen; Karen R Steingart; Sandy Oliver
Journal:  Cochrane Database Syst Rev       Date:  2022-04-26

5.  A Benchtop Automated Sputum-to-Genotype System Using a Lab-on-a-Film Assembly for Detection of Multidrug-Resistant Mycobacterium tuberculosis.

Authors:  Alexander V Kukhtin; Ryan Norville; Arial Bueno; Peter Qu; Nicole Parrish; Megan Murray; Darrell P Chandler; Rebecca C Holmberg; Christopher G Cooney
Journal:  Anal Chem       Date:  2020-03-24       Impact factor: 6.986

6.  Sputum smear-positive, Xpert® MTB/RIF-negative results: magnitude and treatment outcomes of patients in Myanmar.

Authors:  M H Phyu; K W Y Kyaw; Z Myint; A Thida; S Satyanarayana; S T Aung
Journal:  Public Health Action       Date:  2018-12-21

7.  Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016.

Authors:  Danielle Cazabon; Tripti Pande; Sandra Kik; Wayne Van Gemert; Hojoon Sohn; Claudia Denkinger; Zhi Zhen Qin; Brenda Waning; Madhukar Pai
Journal:  Gates Open Res       Date:  2018-07-25

8.  ASAP-GxNet project in Burkina Faso: fulfil country capacity gaps to ensure efficient utilisation of GeneXpert instruments in tuberculosis care and cascade.

Authors:  Riccardo Alagna; Tinnoga Lèon Sawadogo; Adjima Combary; Souba Diandé; Daniela Maria Cirillo
Journal:  ERJ Open Res       Date:  2019-02-01

9.  Performance of the Xpert HIV-1 Viral Load Assay: a Systematic Review and Meta-analysis.

Authors:  Madlen Nash; Sophie Huddart; Sayema Badar; Shrikala Baliga; Kavitha Saravu; Madhukar Pai
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

10.  Measuring and improving the quality of tuberculosis care: A framework and implications from the Lancet Global Health Commission.

Authors:  Catherine Arsenault; Sanam Roder-DeWan; Margaret E Kruk
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.